Takeda Pharmaceutical could acquire in US, Europe, Japan, emerging nations (translated)
04 JUL 2017
Takeda Pharmaceutical [TYO:4502], the Japanese pharmaceutical group, is seeking acquisitions, Frankfurter Allgemeinereported.
Takeda Chief, Christophe Weber told the German daily he wants to grow in the US, Europe and Japan, while emerging nations also have long-term potential. Acquisitions are possible to fill the group's pipeline said Weber, noting that the company is very innovative and brings new medicines to the market very quickly.
Weber said there is always a maximum price he is prepared to pay as he wants to preserve the group's investment grade rating.
External co-operations are more important than buys, Weber stated.
Takeda achieved a turnover of around EUR 13bn in the 2016/17 financial year, the report stated.